GL1X · GenesisL1 explorer

Research workbench

Synthesis and biological evaluation of new triazolo and imidazolopyridine rorgt inverse agonists

Analyse Synthesis and biological evaluation of new triazolo and imidazolopyridine rorgt… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5M96
Type
protein
Length
448 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclear receptor ror-gamma
UniProt
P51449
Ligands
Q6Y
Pockets
10 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 74% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANuclear receptor ror-gammaprotein22574% helix, 4% strandP51449
BNuclear receptor ror-gammaprotein22374% helix, 4% strandP51449

Ligands and binding sites

  • Q6Y · ~{N}-[8-[[(3~{S})-4-cyclopentylcarbonyl-3-methyl-piperazin-1-yl]methyl]-7-methyl-imidazo[1,2-a]pyridin-6-yl]-2-methyl-pyrimidine-5-carboxamide · ligand · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13390.820.9139Q6Y
29870.810.8272Q6Y
33410.810.9041Q6Y
42470.540.7721empty
51310.500.8018empty

Interfaces

1 interface between chains.

  • A–B · 885 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 5M96 · Synthesis and biological evaluation of new triazolo and imidazolopyridine RORgt inverse… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.